Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-25-096008
Filing Date
2025-10-03
Accepted
2025-10-03 14:42:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5319
  Complete submission text file 0001213900-25-096008.txt   7161
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Subject) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-87110 | Film No.: 251373323
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 135 SYCAMORE DRIVE ROSLYN NY 11576
Business Address 135 SYCAMORE DRIVE ROSLYN NY 11576 (516) 521-1354
SEG Opportunity Fund, LLC (Filed by) CIK: 0002041952 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G